ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Cost of Revenue history
Currency unavailable · from the income statement
No Cost of Revenue data reported for this period type.
Cost of Revenue vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $47.71M USD | — | — | 1182.7% | |
| LTM Mar 2026 | $6.67M USD | -73.5% | — | 8.4% | |
| LTM Mar 2026 | $4.46M USD | +106.0% | — | 6.2% | |
| LTM Mar 2026 | $4M USD | — | — | 8.8% | |
| LTM Mar 2026 | $3.09M USD | +178.5% | — | 9.6% | |
| LTM Mar 2026 | €1.38M EUR | — | — | 10.3% | |
| LTM Mar 2026 | $309.37K USD | — | -73.0% | 33.6% | |
| LTM Mar 2026 | $119K USD | -36.4% | — | — | |
| FY2025 | $0 USD | — | — | 0.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — | — |
| Peer median (excluding ADRX) | — | +34.8% | -73.0% | 9.2% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.